Introduction: Male hypogonadism is defined by a low serum testosterone (T) concentration (e.g., < 300 ng/dL) and associated symptoms. A novel oral testosterone undecanoate (TU) formulation[1] now offers hypogonadal men in the U.S. a new treatment option compared to long-standing T replacement...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.